Skip to main content
. 2021 Sep 22;12(3):1363–1376. doi: 10.1016/j.apsb.2021.09.016

Scheme 1.

Scheme 1

Methods for generating d-type lead peptides and whole-body tracking of d-peptides via PET imaging. (A) Mirror-image phage display for generating highly potent d-peptides for target binding. (B) Structure of a tetrapeptide and its retro-inverse analog. (C) Comparison of l-peptides with d-peptides in terms of pharmacological properties. DMPK: drug metabolism and pharmacokinetics. (D) Whole-body tracking of d-peptides for in vivo fate study using PET imaging.